ATE304844T1 - Entzündungshemmende pharmazeutische formulierungen - Google Patents

Entzündungshemmende pharmazeutische formulierungen

Info

Publication number
ATE304844T1
ATE304844T1 AT99928066T AT99928066T ATE304844T1 AT E304844 T1 ATE304844 T1 AT E304844T1 AT 99928066 T AT99928066 T AT 99928066T AT 99928066 T AT99928066 T AT 99928066T AT E304844 T1 ATE304844 T1 AT E304844T1
Authority
AT
Austria
Prior art keywords
pharmaceutical formulations
inflammatory pharmaceutical
steroidal anti
inflammatory drug
inflammatory
Prior art date
Application number
AT99928066T
Other languages
English (en)
Inventor
Austin John Woolfe
Gordon Mcintyre
Sheth Nitin Vadilal
Original Assignee
Norton Healthcare Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Norton Healthcare Ltd filed Critical Norton Healthcare Ltd
Application granted granted Critical
Publication of ATE304844T1 publication Critical patent/ATE304844T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2072Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/557Eicosanoids, e.g. leukotrienes or prostaglandins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2072Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT99928066T 1998-07-01 1999-06-30 Entzündungshemmende pharmazeutische formulierungen ATE304844T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9814215.1A GB9814215D0 (en) 1998-07-01 1998-07-01 Anti-inflammatory pharmaceutical formulations
PCT/GB1999/001951 WO2000001368A1 (en) 1998-07-01 1999-06-30 Anti-inflammatory pharmaceutical formulations

Publications (1)

Publication Number Publication Date
ATE304844T1 true ATE304844T1 (de) 2005-10-15

Family

ID=10834731

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99928066T ATE304844T1 (de) 1998-07-01 1999-06-30 Entzündungshemmende pharmazeutische formulierungen

Country Status (6)

Country Link
EP (1) EP1091731B1 (de)
AT (1) ATE304844T1 (de)
AU (1) AU4519399A (de)
DE (1) DE69927374T2 (de)
GB (1) GB9814215D0 (de)
WO (1) WO2000001368A1 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6319519B2 (en) 1998-07-07 2001-11-20 Norton Healthcare Ltd. Anti-inflammatory pharmaceutical formulations
SE9802973D0 (sv) 1998-09-03 1998-09-03 Astra Ab Immediate release tablet
US6387410B1 (en) * 1998-09-10 2002-05-14 Norton Healthcare Ltd Anti-inflammatory pharmaceutical formulations
CA2259727A1 (en) * 1999-01-18 2000-07-18 Bernard Charles Sherman A two-layer pharmaceutical tablet comprising an nsaid and misoprostol
US6183779B1 (en) * 1999-03-22 2001-02-06 Pharmascience Inc. Stabilized pharmaceutical composition of a nonsteroidal anti-inflammatory agent and a prostaglandin
CA2387288A1 (en) * 1999-10-01 2001-04-12 Norton Healthcare Ltd. Anti-inflammatory pharmaceutical formulations
PT1411900E (pt) * 2001-06-01 2010-10-11 Pozen Inc Composições farmacêuticas para a entrega coordenada de aines
US8206741B2 (en) 2001-06-01 2012-06-26 Pozen Inc. Pharmaceutical compositions for the coordinated delivery of NSAIDs
WO2004091579A1 (en) * 2003-04-16 2004-10-28 Pharmacia Corporation Stabilized prostaglandin formulation
WO2006099618A1 (en) * 2005-03-16 2006-09-21 Dr. Reddy's Laboratories Ltd. Delivery system for multiple drugs
WO2008146178A2 (en) 2007-05-30 2008-12-04 Wockhardt Research Centre A novel tablet dosage form
US20090022786A1 (en) * 2007-07-16 2009-01-22 Yung Shin Pharm. Ind. Co., Ltd. Oral pharmaceutical dosage form and manufacturing method thereof
AU2009290712A1 (en) 2008-09-09 2010-03-18 Astrazeneca Ab Method for delivering a pharmaceutical composition to patient in need thereof
CA2764963C (en) 2009-06-25 2016-11-01 Astrazeneca Ab Method for treating a patient at risk for developing an nsaid-associated ulcer
BR112014016085A8 (pt) 2011-12-28 2017-07-04 Pozen Inc composições aprimoradas e métodos para distribuição de omeprazol mais ácido acetilsalicílico
US10835541B2 (en) 2015-07-30 2020-11-17 Takeda Pharmaceutical Company Limited Tablet

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3488418A (en) * 1965-11-18 1970-01-06 Sterling Drug Inc Sustained relief analgesic composition
CA1259924A (en) * 1985-03-25 1989-09-26 Wallace E. Becker Pharmaceutical tableting method
EP0527887B1 (de) * 1990-05-03 1995-04-26 G.D. Searle & Co. Pharmazeutische zusammensetzung
US6077539A (en) * 1996-11-12 2000-06-20 Pozen, Inc. Treatment of migraine headache

Also Published As

Publication number Publication date
DE69927374D1 (de) 2006-02-02
GB9814215D0 (en) 1998-09-02
EP1091731B1 (de) 2005-09-21
WO2000001368A1 (en) 2000-01-13
DE69927374T2 (de) 2006-06-14
AU4519399A (en) 2000-01-24
EP1091731A1 (de) 2001-04-18

Similar Documents

Publication Publication Date Title
ATE304844T1 (de) Entzündungshemmende pharmazeutische formulierungen
ID27504A (id) Formulasi oral baru
DE69832816D1 (de) Orale pharmazeutische dosierungsform mit verlängerter wirkstofffreisetzung
DE69805001D1 (de) Osmotische darreichungsform mit zwei mantelschichten
RU94032150A (ru) Лекарственное средство с замедленным высвобождением активно-действующего вещества
EE9700194A (et) Peroraalne farmatseutiline annusvorm, mis sisaldab prootonpumba inhibiitorit ja NSAID
ATE228009T1 (de) Orale, pharmazeutische darreichungsformen, die einen protonenpumpeninhibitor und ein antacidum oder alginat enthalten
MX9706769A (es) Formas de dosificacion farmaceutica que comprenden un inhibidor de la bomba de protones y un agente procinetico.
DE69819351D1 (de) Aus mehreren einzeleinheiten zusammengesetzte arzneimittel mit nicht-steroidalen wirkstoffen (nsaids)
ITRM930591A0 (it) Dispositivo medico per la somministrazione di principi attivi o farmaci a bassissimo dosaggio, in particolare di farmaci omeopatici.
AR012614A1 (es) Una composicion farmaceutica para la fabricacion de un medicamento destinado para el tratamiento de una infeccion viral susceptible de tratamientocon interferon alfa, un metodo para la fabricacion de un medicamento, el uso de peg12000-ifn alfa para la fabricacion de un medicamento
ES2161690T3 (es) Formulaciones farmaceuticas.
DE60019334D1 (de) Antivirale arznei
NO20011217D0 (no) Doseringsform omfattende væskeformulering
HRP20010684B1 (hr) Izravno stlaciva matrica za kontrolirano otpustanje jednostruke dnevne doze klaritromicina
MY119722A (en) Swallow tablet comprising paracetamol.
ATE469644T1 (de) Pharmazeutische zubereitung enthaltend n-ä2-(1,6, 7,8-tetrahydro-2h-indenoä5,4 büfuran-8- yl)ethylüpropionamid ummantelt mit einer copolyvidon-enthaltenden, polyäthylenglykolfreien umhüllung
NO20012351L (no) Farmasoytisk sammensetning for modifisert frigjoring av insulinsensibiliserende middel
NL193820B (nl) Vaste farmaceutische doseringsvorm voor orale toediening van Ibuprofen.
DE69710423D1 (de) Orale pharmazeutische Zubereitung mit antipyretischer, analgetischer und entzündungshemmender Wirkung.
AR011437A1 (es) Composicion farmaceutica para el tratamiento de la migrana y el uso de la misma en la preparacion de un medicamento.
NO975634L (no) Stabile farmasöytiske preparater inneholdende tiludronathydrater og fremgangsmåte for fremstilling av farmasöytiske preparater
AR034435A1 (es) Agentes terapeuticos.
ATE158172T1 (de) Pulverförmige pharmazeutische zusammensetzung
DE69907481D1 (de) Entzündungshemmende pharmazeutische formulierungen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties